Abstract:
[(Oxo-3-cyclohexyl)-4 phenyl]-2 propionic acid and its derivatives are prepared by converting (ethylenedioxo-3,3 cyclohexyl)-4 acetophenone or its derivatives, of general formula (IV) in which A denotes a group (a), B denotes a group (b), and R , R , R , R , R , which may be identical or different, each denote hydrogen or an alkyl group, to a desired compound of general formula (I), in which A denotes a group (c). This process is easier to implement on an industrial scale and produces a higher yield than prior art processes for preparing compounds of formula (I).
Abstract:
Compounds of the formulas (I), (II) and (III), where R , R , R and R are hydrogen or methyl, X is hydrogen or fluorine and Q is formula (IV), (V), (VI), (VII), (VIII), or (IX), and X is hydrogen, hydroxy, methoxy or fluorine, R is hydroxy, alkoxy with 0 or 1 hydroxy substituent, aroxy or NR R , where R is hydrogen, alkyl with 0 or 1 hydroxy substituent or aryl, and R is alkyl with 0 or 1 hydroxy substituent or aryl, with the provisos that X is fluorine only when R is methyl, when R or R is methyl the other R or R is also methyl and when Q is said thienyl group Q may be in either the cis or trans position. These compounds are useful as chemopreventive agents for inhibiting tumor promotion in epithelial cells and for treating nonmalignant skin disorders.
Abstract:
The present invention describes compounds and uses thereof in applications relating to absorption of electromagnetic energy. Preferred compounds are double bond-containing cyclic compounds capable of absorbing electromagnetic radiation energy and having improved photostability due to the presence and location of one or more fluorine groups in relation to the double bond of the ring.
Abstract:
La présente invention concerne un procédé de préparation d'un composé de formule (I) par réaction entre un composé de formule (II) et un composé de formule (III) en l'absence de catalyseur notamment de catalyseur métallique, et de ligand, et en présence d'une base (I), (II), (III). L'invention concerne également l'utilisation de ce procédé pour la préparation de composés d'intérêt, notamment du Tamoxifen.
Abstract:
Methods described herein enable the production of numerous molecular species through decarboxylative cross-coupling via use of photoredox and transition metal catalysts. For example, methods described herein enable the production of numerous molecular species through decarboxylative cross-coupling via use of photoredox and transition metal catalysts. A method described herein, in some embodiments, comprises providing a reaction mixture including a photoredox catalyst, a transition metal catalyst, a coupling partner and a substrate having a carboxyl group. The reaction mixture is irradiated with a radiation source resulting in cross-coupling of the substrate and coupling partner via a mechanism including decarboxylation, wherein the coupling partner is selected from the group consisting of a substituted aromatic compound and a substituted aliphatic compound.
Abstract:
The present disclosure relates to compounds to be used in a low dose in treatment of neurodegenerative diseases or disorders. It also relates to methods for treatment of a neurodegenerative diseases or disorders.
Abstract:
This invention relates to novel compounds having the structural formula I below: and to their pharmaceutically acceptable salt, compositions and methods of use. These novel compounds provide a treatment or prophylaxis of cognitive impairment, Alzheimer Disease, neurodegeneration and dementia.
Abstract:
Die vorliegende Erfindung betrifft die Verbesserung organischer Elektrolumineszenzvorrichtungen, insbesondere blau emittierender Vorrichtungen, indem Verbindungen gemäß Formel (1) als Dotanden in der emittierenden Schicht verwendet werden.
Abstract:
Die vorliegende Erfindung betrifft die Verbesserung organischer Elektrolumineszenzvorrichtungen, insbesondere blau emittierender Vorrichtungen, indem Verbindungen gemäß Formel (1) als Dotanden in der emittierenden Schicht verwendet werden.